VivoSim Labs (VIVS) Shares Outstanding (2011 - 2026)
VivoSim Labs (VIVS) posted Shares Outstanding (Entity) of $5.2 million for Q2 2026, up 81.01% on a QoQ basis from $2.9 million in Q1 2026, and up 101.53% year-over-year from $2.6 million in Q2 2025.
Analysis
VivoSim Labs (VIVS) Shares Outstanding (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Shares Outstanding (Entity) for 16 years, with the latest figure at $5.2 million in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 101.53% year-over-year to $5.2 million in Q2 2026; TTM through Jun 2026 was $5.2 million, a 101.53% increase from a year earlier, with the FY2026 full-year figure at $2.9 million, up 97.77% from the prior year.
- Shares Outstanding (Entity) was $5.2 million for Q2 2026 at VivoSim Labs, up from $2.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $5.2 million in Q2 2026, with the low at $725857.0 in Q1 2022.
- Average Shares Outstanding (Entity) over 5 years is $1.6 million, with a median of $1.0 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) advanced 0.07% in 2023, then surged 117.06% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $726187.0 in 2022, then advanced by 12.9% to $819863.0 in 2023, then surged by 74.14% to $1.4 million in 2024, then jumped by 82.67% to $2.6 million in 2025, then jumped by 100.9% to $5.2 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $5.2 million (Q2 2026), $2.9 million (Q1 2026), and $2.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 166.10 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 28.17 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 78.42 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 48.02 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 94.80 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 355.16 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 62.09 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 13.90 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 46.38 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 5.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.24 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 1.22 Mn |
| Mar 31, 2024 | 762,046.00 |
| Dec 31, 2023 | 759,591.00 |
| Sep 30, 2023 | 726,513.00 |
| Jun 30, 2023 | 726,407.00 |
| Mar 31, 2023 | 726,057.00 |
| Dec 31, 2022 | 726,106.00 |
| Sep 30, 2022 | 725,995.00 |
| Jun 30, 2022 | 725,885.00 |
| Mar 31, 2022 | 725,271.00 |
| Dec 31, 2021 | 725,430.00 |
| Sep 30, 2021 | 725,415.00 |